Skip to main content

Innosuisse — Portfolio, Page 4

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

213
Companies
$552.7M
Total invested
$2.8M
Avg. check
46
Industries
Biotechnology 8Health Care 8Manufacturing 5Medical Device 5Life Science 5Medical 4+40 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 73–96 of 213
Pace Locator
February 2025

Pace Locator device generates 3D maps of cardiac signal origin using ECG and ECHO data.

Manufacturing · Biel$335K Pre-Seed
Enerdrape
February 2026

Enerdrape is a geothermal technology firm that turns underground spaces into sources of energy for heating and cooling needs of buildings.

Clean Energy · Renens$517K Debt Financing
EVis Bioscience
February 2026

EVis Bioscience offers gene delivery solutions using extracellular vesicles, lipid nanoparticles, and hybrid systems.

Genetics · Schlieren$873K Pre-Seed
CompPair
February 2026

CompPair is solving damage issues for the composite materials industry by developping smart sustainable textile systems.

3D Printing · LausanneUndisclosed
ExerGo Sàrl
February 2026

ExerGo provides energy concepts, feasibility studies, and engineering services for thermal network projects.

Service Industry · Yverdon-les-bainsVenture - Series Unknown
AMPLY Discovery
February 2026

AMPLY uses machine learning and synthetic biology to mine vast biological data to discover novel drug and nutraceutical candidates.

Artificial Intelligence (AI) · BelfastCorporate Round
Multiwave Technologies
September 2025

Multiwave is a deep tech company developing disruptive medical imaging devices

Advanced Materials · Geneva$4.5M Venture - Series Unknown
Veezoo
September 2025

Veezoo is a software company that develops analytics solution for business insights from cloud databases using natural-language.

Analytics · Zürich$6.0M Series A
Cutiss
September 2025

Cutiss is a life science company that engages in regenerative medicine production, skin tissue engineering, and curated therapy solutions.

Beauty · Zürich$38.9M Series C
Cellvie
September 2025

Cellvie develops cell-derived medicines, leveraging the therapeutic potential of mitochondria, the powerhouses of the cell.

Biotechnology · Houston$5.0M Seed
Manukai
March 2025

Manukai, an ETH Zurich spin-off, creates novel AI models to unlock the value of production data in metal machining.

CAD · Zurich$3.0M Pre-Seed
machineMD
March 2025

machineMD combines virtual reality and artificial intelligence into a medical device for the early diagnosis of neurological disorders

Artificial Intelligence (AI) · BernVenture - Series Unknown
MPower Ventures
March 2025

MPower Ventures is a technology company that offers funding, software, and solar products to facilitate energy access in emerging markets.

CleanTech · Zúrich$2.7M Venture - Series Unknown
Akina
January 2025

Akina provides AI-enabled connected therapy for patients with musculoskeletal conditions.

Health Care · Zúrich$3.2M Seed
Embotech
December 2024

Embotech is an IT consulting firm that provides autonomous driving solutions for industrial logistics applications.

Autonomous Vehicles · Zúrich$26.3M Series B
Lyfegen
December 2024

Lyfegen is SaaS company that develops rebate management software for the healthcare industry.

Electronic Health Record (EHR) · Basel$5.7M Series A
ZuriMED Technologies AG
November 2024

An Innovation Engine In Sports Medicine

Medical Device · Zurich$2.6M Series A
Neustark
June 2024

Neustark is a concrete producer in bern using wastewater treatment plant by turning CO2 into minerals.

Building Material · Berne$69.0M Venture - Series Unknown
LEDCity
April 2024

LEDCity is a energy technology company that designs and develops efficient lighting systems for commercial buildings.

CleanTech · Zurich$2.2M Venture - Series Unknown
Volumina Medical
March 2024

Volumina Medical is a healthcare technology company that engages develops injectable 3D scaffolds for the reconstruction of soft tissues.

Biotechnology · Epalinges$21.0M Series A
Hemotune
March 2024

Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.

Biotechnology · Schlieren$15.6M Series B
TissueLabs
March 2024

TissueLabs is a biotechnology research company that operates a platform for creating organs and tissues in the lab.

3D Printing · Bellinzona$800K Pre-Seed
Galventa
December 2023

Galventa provides pharmaceutical manufacturing services for a micro-pellet-based food supplement that relieves sleep inertia symptoms.

Biotechnology · Saint Gallen$1.8M Seed
Scailyte
December 2023

True precision medicine through single-cell science

Artificial Intelligence (AI) · Basel$1.8M Series A

Where Innosuisse invests

Biotechnology8
Health Care8
Manufacturing5
Medical Device5
Life Science5
Medical4

About Innosuisse's portfolio

How many companies has Innosuisse invested in?▸

Innosuisse has invested in 213 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Innosuisse invest in?▸

Innosuisse's top investment sectors include Biotechnology, Health Care, Manufacturing, Medical Device, Life Science. The firm invests across 46 different industry categories.

What is Innosuisse's largest investment?▸

Among tracked funding rounds, Neustark received $69.0M in a Venture - Series Unknown round. Innosuisse's total known invested capital is $552.7M.

What is the average investment size for Innosuisse?▸

Innosuisse's average investment size is $2.8M across its portfolio of 213 companies.

What are Innosuisse's most recent investments?▸

Recent Innosuisse portfolio additions include Pace Locator, Enerdrape, EVis Bioscience, CompPair, ExerGo Sàrl. These companies were founded in 2020 or later.

Reach the founders behind these 213 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →